P4‐346: Safety, tolerability and biomarker effects of an Abeta monoclonal antibody administered to patients with Alzheimer's disease
Siemers E, Friedrich S, Dean R, Sethuraman G, DeMattos R, Jennings D, Tamagnan G, Marek K, Seibyl J. P4‐346: Safety, tolerability and biomarker effects of an Abeta monoclonal antibody administered to patients with Alzheimer's disease. Alzheimer's & Dementia 2008, 4: t774-t774. DOI: 10.1016/j.jalz.2008.05.2416.Peer-Reviewed Original Research